No Sanctions For GSK, But Both Sides Told To 'Dial It Back'
By Chris Villani · February 20, 2020, 3:05 PM EST
GlaxoSmithKline will not face sanctions for a call to the U.S. Food and Drug Administration tied to multidistrict litigation over whether its anti-nausea medication Zofran causes birth defects, a Boston federal...
To view the full article, register now.